Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atanu Haldar

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Inorganic Chemistry|June 29, 2021
Devising a Polyoxometalate-Based Functional Material as an Efficient Electrocatalyst for the Hydrogen Evolution ReactionChandani Singh, Atanu Haldar, Olivia Basu, et al.
Clinical and Vaccine Immunology : CVI|February 11, 2011
Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancerSoumyabrata Roy, Shyamal Goswami, Anamika Bose, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 20, 2011
Defective dendritic cell generation from monocytes is a potential reason for poor therapeutic efficacy of interferon α2b (IFNα2b) in cervical cancerSoumyabrata Roy, Shyamal Goswami, Anamika Bose, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Inorganic Chemistry|June 29, 2021
Devising a Polyoxometalate-Based Functional Material as an Efficient Electrocatalyst for the Hydrogen Evolution ReactionChandani Singh, Atanu Haldar, Olivia Basu, et al.
Clinical and Vaccine Immunology : CVI|February 11, 2011
Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancerSoumyabrata Roy, Shyamal Goswami, Anamika Bose, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 20, 2011
Defective dendritic cell generation from monocytes is a potential reason for poor therapeutic efficacy of interferon α2b (IFNα2b) in cervical cancerSoumyabrata Roy, Shyamal Goswami, Anamika Bose, et al.
Pageof 1